These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2566254)

  • 1. Myoclonic encephalopathy due to bismuth salts: treatment with dimercaprol and analysis of CSF transmitters.
    Molina JA; Calandre L; Bermejo F
    Acta Neurol Scand; 1989 Mar; 79(3):200-3. PubMed ID: 2566254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
    Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD
    Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalopathy associated with bismuth subgallate therapy.
    Friedland RP; Lerner AJ; Hedera P; Brass EP
    Clin Neuropharmacol; 1993 Apr; 16(2):173-6. PubMed ID: 8477413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bismuth Subgallate Toxicity in the Age of Online Supplement Use.
    Sampognaro P; Vo KT; Richie M; Blanc PD; Keenan K
    Neurologist; 2017 Nov; 22(6):237-240. PubMed ID: 29095326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory difficulty following bismuth subgallate aspiration.
    Murray AD; Gibbs SR; Billings KR; Biavati MJ
    Arch Otolaryngol Head Neck Surg; 2000 Jan; 126(1):79-81. PubMed ID: 10628716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myoclonic and convulsive encephalopathy caused by bismuth. Usefulness of dimercaprol treatment].
    Nogué S; Mas A; Parés A; Nadal P; Bertrán A; Torra M; Bachs M; Blesa R
    Med Clin (Barc); 1985 Apr; 84(13):530-2. PubMed ID: 3999823
    [No Abstract]   [Full Text] [Related]  

  • 7. Amino acid levels in cerebrospinal fluid of rats after administration of pentylenetetrazol.
    Halonen T; Pitkänen A; Partanen J; Hyttinen JM; Riekkinen PJ
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992; 101(1):21-5. PubMed ID: 1350965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoclonic encephalopathy caused by chronic bismuth abuse.
    Teepker M; Hamer HM; Knake S; Bandmann O; Oertel WH; Rosenow F
    Epileptic Disord; 2002 Dec; 4(4):229-33. PubMed ID: 12600808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Persistent hallucinatory symptoms in a case of bismuth encephalopathy].
    Saiz Ruiz J; Anchústegui Melgarejo C; San Sebastián Cabasés J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(6):427-33. PubMed ID: 6535395
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute delirium in bismuth poisoning].
    Mattle H; Henn V; Baumgartner G
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1308-11. PubMed ID: 7134955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary sequelae of intraparenchymal bismuth subgallate.
    Cozzi LM; Megerian CA; Dugue C; Barcello M; Abdul-Karim FW; Arnold JE; Maniglia AJ
    Laryngoscope; 1992 Jun; 102(6):597-9. PubMed ID: 1602906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myoclonic encephalopathy caused by lead intoxication].
    Vivancos Matellano FV; Caminero AB; Frank A; Díez Tejedor E; Barreiro P
    Neurologia; 1993; 8(6):205-6. PubMed ID: 8352979
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comment on the contribution by J. Strutz. Bismuth gallate in wound management].
    Greusing B
    HNO; 1996 Aug; 44(8):426. PubMed ID: 8964713
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fatal hepatic necrosis due to a treatment course of rheumatoid arthritis with gold salts].
    Van Linthoudt D; Buss W; Beyner F; Ott H
    Schweiz Med Wochenschr; 1991 Jul; 121(30):1099-102. PubMed ID: 1678206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new case of colitis caused by gold salts].
    Bergeret A; Deltombe B; Piolet I; Vial T
    J Toxicol Clin Exp; 1988; 8(6):419-21. PubMed ID: 2908801
    [No Abstract]   [Full Text] [Related]  

  • 16. Bismuth absorption from 205Bi-labelled pharmaceutical bismuth compounds used in the treatment of peptic ulcer disease.
    Dresow B; Fischer R; Gabbe EE; Wendel J; Heinrich HC
    Scand J Gastroenterol; 1992 Apr; 27(4):333-6. PubMed ID: 1589712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bismuth gallate in wound treatment].
    Vanscheidt W
    HNO; 1995 Dec; 43(12):740. PubMed ID: 8582836
    [No Abstract]   [Full Text] [Related]  

  • 18. Pitfall-to-avoid pharyngeal opacities caused by bismuth subgallate.
    Tannous WN; Azouz EM; Tewfik TL
    Can Assoc Radiol J; 1989 Dec; 40(6):312. PubMed ID: 2598077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does bismuth subgallate have haemostatic effects in tonsillectomy?
    Sørensen WT; Henrichsen J; Bonding P
    Clin Otolaryngol Allied Sci; 1999 Feb; 24(1):72-4. PubMed ID: 10196655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth intoxication treated with B.A.L.
    COCHRANE GC
    East Afr Med J; 1952 Apr; 29(4):142-3. PubMed ID: 14936904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.